@conference{ad4a2b070ad4499ebc90d2368a586a28,
title = "Unrelated Donor T-Cell Depleted (TCD) Hematopoietic Stem Cell Transplantation (HSCT) for Patients with Advanced Myelodysplastic Syndromes (MDS): The MSKCC Experience",
author = "Chung, \{Stephen S.\} and Goldberg, \{Jenna D\} and Papadopoulos, \{Esperanza B.\} and Jakubowski, \{Ann A.\} and Sean Devlin and Farid Boulad and Miguel Perales and Kernan, \{Nancy A.\} and Ponce, \{Doris M\} and Small, \{Trudy N\} and Guenther Koehne and Barker, \{Juliet N\} and O'Reilly, \{Richard J.\} and Giralt, \{Sergio A\} and \{van den Brink\}, \{Marcel R.M.\} and Young, \{James W.\} and Castro-Malaspina, \{Hugo R\}",
note = "Abstract 1996 The outcomes of unrelated HSCT have markedly improved with the advent of high resolution HLA-typing. However, graft-versus host disease (GvHD) remains a limiting factor, particularly in mismatched transplants. Several studies have demonstrated that TCD reduces the incidence of acute and chronic GvHD, potentially allowing for improved outcomes in the mismatched setting.; Blood ; Conference date: 01-01-2020",
year = "2012",
month = nov,
day = "16",
language = "American English",
}